The Coca-Cola Company reported Q3 earnings and sales that topped consensus analyst estimates, on strong international growth and a shift away from sugared soft drinks (check back later for KO's latest earnings call transcript). Net income climbed 13% to $1.65 billion, good for EPS of $0.71, versus $0.62 a year earlier. A $0.03 a share restructuring charge was offset by a $0.03 a share gain from the sale of a chunk of its holdings in Coca-Cola Amatil. Revenue grew 19% to $7.69 billion; analysts were, on average, expecting EPS of $0.68 on sales of $7.29 billion. The company said "performance in our Latin America, Africa, Eurasia and Pacific operating groups remained robust." Global unit case volume grew 6%, powered by still (non-carbonated) beverage unit case volume which was up 14%. YTD cash from operations increased 18%. As part of its shift away from sugared soft drink beverages, which health conscious consumers have been avoiding, Coke purchased Glaceau (Vitaminwater) for $4.1 billion in May (full summary). YTD, Coke has repurchased $1.6 billion of its own shares; the company doesn't offer forward guidance. Its shares are up nearly 20% this year.
Commentary: Coca-Cola Launches Chinese Medicine Research Center in Beijing • Coca-Cola Beats on Strong International Sales • Coca-Cola to Acquire Glaceau (Vitaminwater) for $4.1B
Stocks to watch: KO. Competitors: PEP, CSG. ETFs: UGE, VDC, PRFG
Earnings call transcript: Coca-Cola Q2 2007
Seeking Alpha's news briefs are combined into a pre-market summary called Wall Street Breakfast. Get Wall Street Breakfast by email -- it's free and takes only seconds to sign up.